Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Pharma
With 64 centers activated, bluebird is ready to grow Lyfgenia
Bluebird has started its first patient on its sickle cell disease gene therapy Lyfgenia. And, with 64 treatment centers active, there's room to grow.
Kevin Dunleavy
May 9, 2024 1:40pm
Pfizer charges $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel
Apr 23, 2024 11:16am
Kyowa's Orchard hopes $4.25M gene therapy price tag bears fruit
Mar 20, 2024 10:40am
Orchard nabs approval for first MLD gene therapy in US
Mar 18, 2024 3:25pm
BIO-WuXi, Takeda, FDA-Carvykti—Fierce Pharma Asia
Mar 15, 2024 10:15am